Literature DB >> 7689426

Mapping of antigenic determinants of the adenine-nucleotide translocator and coxsackie B3 virus with synthetic peptides: use for the diagnosis of viral heart disease.

P L Schwimmbeck1, N K Schwimmbeck, H P Schultheiss, B E Strauer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689426     DOI: 10.1006/clin.1993.1109

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  5 in total

1.  Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection.

Authors:  Rakesh H Basavalingappa; Rajkumar Arumugam; Ninaad Lasrado; Bharathi Yalaka; Chandirasegaran Massilamany; Arunakumar Gangaplara; Jean-Jack Riethoven; Shi-Hua Xiang; David Steffen; Jay Reddy
Journal:  Mol Immunol       Date:  2020-06-29       Impact factor: 4.407

Review 2.  The humoral immune response in viral heart disease: characterization and pathophysiological significance of antibodies.

Authors:  Peter L Schwimmbeck; Boris Bigalke; Karsten Schulze; Matthias Pauschinger; Uwe Kühl; Heinz-Peter Schultheiss
Journal:  Med Microbiol Immunol       Date:  2004-02-04       Impact factor: 3.402

3.  Throat infection, neck and chest pain and cardiac response: a persistent infection-related clinical syndrome.

Authors:  Changqing Zhou; Xiangning Fu; Jiangtao Yan; Qiao Fan; Zhuoya Li; Katherine Cianflone; Daowen Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

Review 4.  Relevance of molecular mimicry in the mediation of infectious myocarditis.

Authors:  Chandirasegaran Massilamany; Sally A Huber; Madeleine W Cunningham; Jay Reddy
Journal:  J Cardiovasc Transl Res       Date:  2013-11-22       Impact factor: 4.132

Review 5.  The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology.

Authors:  Lee A Meier; Bryce A Binstadt
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.